An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Oct 31 2014Iraqi Kurdish soldiers and Syrian rebels join the battle against ISIS in Kobani, the search continues for missing students in Mexico, and the last U-S Marines pull out of a key base in Afghanistan: Please join us to discuss this week's top international stories

Friday News Roundup – Domestic

Friday, Oct 31 2014Last-minute campaigning with just days to go before the midterm elections. The Federal Reserve ends its bond-buying program. And debate continues over Ebola quarantines in the U-S. A panel of journalists joins Diane for a conversation about the week's top stories.